PRX002

· Prothena Biosciences Limited

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PRX002, covering 2015-02-10 to 2016-10-21. Get the full timeline:

Most recent: Clinical Trial Update: Multiple Ascending Dose Study of PRX002 in Patients With Parkinson's Disease [Phase 1]